Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Watkins

Showing results (811-820 of 845) with videos related to

Pageof 85
Sort By:
Antimicrobial Agents and Chemotherapy|April 18, 2022
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing ImportanceAndrea M Hujer, Christopher R Bethel, Magdalena A Taracila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Annals of the New York Academy of Sciences|May 9, 2012
Understanding chronic inflammatory and neuropathic painJane P Hughes, Iain Chessell, Richard Malamut, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activationPeter M Grace, Keith A Strand, Erika L Galer, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
Brain, Behavior, and Immunity|December 28, 2020
Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related painAndrew J Kwilasz, Suzanne M Green Fulgham, Julissa Chante Duran-Malle, et al.
Brain, Behavior, and Immunity|August 15, 2009
Evidence that opioids may have toll-like receptor 4 and MD-2 effectsMark R Hutchinson, Yingning Zhang, Mitesh Shridhar, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
The Journal of Trauma and Acute Care Surgery|October 22, 2015
The found down patient: A Western Trauma Association multicenter studyBenjamin M Howard, Lucy Z Kornblith, Amanda S Conroy, et al.
Pageof 85

Showing results (811-820 of 845) with videos related to

Sort By:
Pageof 85
Antimicrobial Agents and Chemotherapy|April 18, 2022
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing ImportanceAndrea M Hujer, Christopher R Bethel, Magdalena A Taracila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Annals of the New York Academy of Sciences|May 9, 2012
Understanding chronic inflammatory and neuropathic painJane P Hughes, Iain Chessell, Richard Malamut, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activationPeter M Grace, Keith A Strand, Erika L Galer, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
Brain, Behavior, and Immunity|December 28, 2020
Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related painAndrew J Kwilasz, Suzanne M Green Fulgham, Julissa Chante Duran-Malle, et al.
Brain, Behavior, and Immunity|August 15, 2009
Evidence that opioids may have toll-like receptor 4 and MD-2 effectsMark R Hutchinson, Yingning Zhang, Mitesh Shridhar, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
The Journal of Trauma and Acute Care Surgery|October 22, 2015
The found down patient: A Western Trauma Association multicenter studyBenjamin M Howard, Lucy Z Kornblith, Amanda S Conroy, et al.
Pageof 85